Antimicrobial Therapy and Antimicrobial Stewardship in Sepsis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seok, Hyeri | - |
dc.contributor.author | Jeon, Ji Hoon | - |
dc.contributor.author | Park, Dae Won | - |
dc.date.accessioned | 2021-08-31T08:43:00Z | - |
dc.date.available | 2021-08-31T08:43:00Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2020-03 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/57438 | - |
dc.description.abstract | Since sepsis was first defined, sepsis management has remained challenging. To improve mortality rates for sepsis and septic shock, an accurate diagnosis and prompt administration of appropriate antibiotics are essential. The goals of antimicrobial stewardship are to achieve optimal clinical outcomes and to ensure cost-effectiveness and minimal unintended consequences, such as toxic effects and development of resistant pathogens. A combination of inadequate diagnostic criteria for sepsis and time pressure to provide broad-spectrum antimicrobial therapy remains an obstacle for antimicrobial stewardship. Efforts such as selection of appropriate empirical antibiotics and de-escalation or determination of whether or not to stop antibiotics may help to improve a patient's clinical prognosis as well as the successful implementation of antimicrobial stewardship. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC ANTIMICROBIAL THERAPY | - |
dc.subject | VENTILATOR-ASSOCIATED PNEUMONIA | - |
dc.subject | INFECTIOUS-DISEASES SOCIETY | - |
dc.subject | COURSE ANTIBIOTIC-THERAPY | - |
dc.subject | URINARY-TRACT-INFECTIONS | - |
dc.subject | HEALTH-CARE EPIDEMIOLOGY | - |
dc.subject | BLOOD-STREAM INFECTIONS | - |
dc.subject | INTENSIVE-CARE | - |
dc.subject | DE-ESCALATION | - |
dc.subject | CRITICALLY-ILL | - |
dc.subject | SEPTIC SHOCK | - |
dc.title | Antimicrobial Therapy and Antimicrobial Stewardship in Sepsis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Seok, Hyeri | - |
dc.contributor.affiliatedAuthor | Park, Dae Won | - |
dc.identifier.doi | 10.3947/ic.2020.52.1.19 | - |
dc.identifier.scopusid | 2-s2.0-85084318063 | - |
dc.identifier.wosid | 000522779300002 | - |
dc.identifier.bibliographicCitation | INFECTION AND CHEMOTHERAPY, v.52, no.1, pp.19 - 30 | - |
dc.relation.isPartOf | INFECTION AND CHEMOTHERAPY | - |
dc.citation.title | INFECTION AND CHEMOTHERAPY | - |
dc.citation.volume | 52 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 19 | - |
dc.citation.endPage | 30 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002575648 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.subject.keywordPlus | VENTILATOR-ASSOCIATED PNEUMONIA | - |
dc.subject.keywordPlus | INFECTIOUS-DISEASES SOCIETY | - |
dc.subject.keywordPlus | COURSE ANTIBIOTIC-THERAPY | - |
dc.subject.keywordPlus | URINARY-TRACT-INFECTIONS | - |
dc.subject.keywordPlus | HEALTH-CARE EPIDEMIOLOGY | - |
dc.subject.keywordPlus | BLOOD-STREAM INFECTIONS | - |
dc.subject.keywordPlus | INTENSIVE-CARE | - |
dc.subject.keywordPlus | DE-ESCALATION | - |
dc.subject.keywordPlus | CRITICALLY-ILL | - |
dc.subject.keywordPlus | SEPTIC SHOCK | - |
dc.subject.keywordAuthor | Sepsis | - |
dc.subject.keywordAuthor | Septic shock | - |
dc.subject.keywordAuthor | Antibiotics | - |
dc.subject.keywordAuthor | Antimicrobial stewardship | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.